WallachBeth Capital, an institutional brokerage firm, has created a healthcare research group. The new WallachBeth Healthcare Research Group includes a team of six that recently joined the firm from Auriga USA, the U.S. subsidiary of Madrid-based Auriga Global Investors.

The new group will focus on providing clients with detailed company analysis, information flow, investment ideas and access to industry thought leaders across key healthcare verticals including life science tools, diagnostics, clinical labs, specialty pharmaceuticals, biotech and healthcare services.

Senior managing directors Douglas Bantum and Gene McNeil Jr. will lead the new WallachBeth division. Bantum and McNeil most recently served as co-heads of equity sales and trading for Auriga USA and previously worked together as senior vice presidents for the institutional research boutique Capstone Investments.

WallachBeth Capital specializes in order execution for exchange-traded products, option strategies and large block equities.

Subscribe Now

Access to premium content including in-depth coverage of mutual funds, hedge funds, 401(K)s, 529 plans, and more.

3-Week Free Trial

Insight and analysis into the management, marketing, operations and technology of the asset management industry.